Chemically modified peanut extract shows increased safety while maintaining immunogenicity
Allergy Dec 06, 2018
van der Kleij HPM, et al. - Authors gauged the immunogenicity, allergenicity and immunotherapeutic efficacy of a well characterized chemically modified peanut extract (MPE) adsorbed to Al(OH)3. They performed competitive IgE-binding assays and mediator release assays using sera of patients. Reduced allergenicity was demonstrated by an Al(OH)3 adsorbed MPE vs unmodified peanut extract (PE), while the efficacy of immunotherapy is maintained. In all patients, the IgE-binding and capacity to induce allergic symptoms of MPE was lower compared to PE.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries